Treatment of relapsed or refractory adult acute lymphocytic leukemia
Open Access
- 1 February 1992
- Vol. 69 (3) , 709-716
- https://doi.org/10.1002/1097-0142(19920201)69:3<709::aid-cncr2820690318>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factorAnnals of Hematology, 1991
- Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemiaCancer, 1989
- Therapy of Refractory Adult Acute Lymphoblastic Leukemia with Vincristine and Prednisone plus Tandem Methotrexate and L-Asparaginase Results of a Cancer and Leukemia Group B StudyAmerican Journal of Clinical Oncology, 1986
- Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaThe American Journal of Medicine, 1986
- Treatment of childhood acute lymphoblastic leukemia with intermediate‐dose cytosine arabinoside and adriamycinMedical and Pediatric Oncology, 1986
- High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemiaEuropean Journal of Cancer and Clinical Oncology, 1985
- Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaLeukemia Research, 1984
- Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexateBMJ, 1978
- Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)American Journal of Hematology, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958